Clinical Topics

Articles

Jackson Heart Study participants who maintained a healthy BP, BMI, and never smoked were at lower risk for incident CVD, suggesting targets for intervention in high-risk populations. 

Black Adults Avoid Hypertension, Reduce CVD Risk with Sustained Lifestyle Habits   

In individuals with chronic coronary disease, the presence of diabetes increased the rate of death by 38% during a 5-year follow-up period in analysis of a worldwide patient registry. 

Diabetes in Patients with CAD Independently Associated with Mortality, CV Events 

Study authors looked for the first time at the impact of bariatric surgery on incidence of all-cause and obesity-related cancer in patients with severe obesity and fatty liver disease. 

In Adults with NAFLD and Severe Obesity, Bariatric Surgery Significantly Reduces Cancer Risk 

Videos

Asthma of obesity affects more than 10% of men and 14% of women with obesity. Our interview with researcher Anne Dixon, MD, sheds light on this poorly appreciated asthma phenotype. 

Asthma of Obesity: Investigator Explains the Phenotypes

Board-certified Physician Assistant and a Fellow of the Obesity Medicine Association. Ms. Burridge earned her Certificate of Advanced Education in Obesity Medicine in 2017. She is the President of PAs in Obesity Medicine and serves on the Board of the Illinois Obesity Society. 

Obesity medicine specialist, Karli Burridge, PA-C, MMS, discusses how and why physicians can further support and engage patients with obesity through the art of communication. 

Provider-Patient Communication: How Better Conversations Can Support Better Outcomes

ENDO 2021: Patients with severe obesity hospitalized for COVID-19 were twice as likely to require ICU admission vs those with normal BMI, according to new findings. 

Obese Patients with COVID-19 at Higher Risk for ICU Admission, Longer Stay 

A lifestyle intervention targeting women with obesity and infertility is more effective in increasing the pregnancy rate vs fertility treatments, suggests a new study presented at ENDO 2021.

Study: Lifestyle Program Improves Fertility in Women with Obesity and Infertility

ENDO 2021: An investigational once-weekly insulin formulation was found as effective as daily basal insulin injection for glucose control with lower rates of hypoglycemia and less weight gain. 

Novel Once-weekly Insulin as Effective as Once-daily in Type 2 Diabetes with Less Hypoglycemia, Weight Gain  

ENDO 2021: Obese individuals treated with semaglutide 2.4 mg vs placebo demonstrated improvements in body composition paralleling weight loss that may reduce risk for cardiometabolic disease.   

Semaglutide 2.4 mg Reduces Visceral Adiposity, Improves Lean Body Mass-to-Fat Mass Ratio 

More than half of adults with obesity who received once-weekly semaglutide lost 15% of body weight, according to the recently published STEP 1 study.